fashion -WSS

fashion

author：comprehensive 2025-09-30 15:15:40 - browse：265

Jennifer Doudna Feng Zhang CRISPR — CRISPR pioneers Jennifer Doudna and Feng Zhang Illustration: STAT; Photos: AP, Getty

The revolution started in silence.

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists, published their first paper announcing a new enzyme for editing DNA in Science in June 2012. It was called CRISPR-Cas9. It wasn’t until January 2013 that the first paper showing the enzyme would work in cells, from Feng Zhang, was published, also in Science. A similar paper from George Church came out at the same time.

No major media outlet covered the papers. The first story on CRISPR was published that March. But within the ivory tower of academia, it was clear something big was building, as requests for the technology poured in from other researchers and Zhang set up an assembly line in his laboratory to distribute it, with students carrying carefully packed samples to a FedEx office down the street.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： J&J reports mixed data on next

focus

WSS

Medicare to cover more brain scans for Alzheimer’s patients

STAT Virtual Event: The State of Biosimilars: What to Watch

Unmasking the 'centricity' illusion in clinical trials

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

knowledge

fashion

focus

As demand for Covid shots wanes, Moderna seeks its next success

Medicare has a new plan to address drug shortages

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why we need mandatory labeling of GMO products

Novavax promises a turnaround & Lilly roils the obesity market

At Orexo, a ‘turning point’ for everything but digital health

Hepatitis C has a cure — but many Americans still lack access to it

Lawsuit challenges CMS nursing home minimum staffing rule

Affirmative action in medical school literally saved lives

Decentralized clinical trials need collaboration to achieve wider use

focus

Achieving telehealth equity for people with hearing loss

J&J reports mixed data on next

U.S. death rates show how politics are affecting public health

Achieving telehealth equity for people with hearing loss

How Medicaid coverage policies for immigrants impact new moms

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

hotspot

knowledge

focus